Model 3150 IPG
Inspire Medical Systems · Decision date Oct 13, 2026
What did the FDA decide?
The FDA record for P130008/S146, a 30-Day Notice dated 2026-10-13 with decision OK30, describes dimensional changes to the transport fixture used for the Model 3150 Implantable Pulse Generator PCBA. It also covers an added visual inspection of the microcontroller unit before final device assembly. The listed supplement reason is a process change involving manufacturer, sterilizer, packager or supplier; the specialty field is anesthesiology and the product code is MNQ.
The S146 identifier ties this notice to the original P130008 approval for Inspire Medical Systems, but a supplement is not a new approval of the whole system and this is a manufacturing notice, not an original PMA. The statement gives the reported purpose of the changes, not independent proof of safety or clinical effectiveness; it does not describe fixture dimensions, inspection criteria or acceptance limits.
FDA approval order statement
approval for dimensional modifications to the Model 3150 Implantable Pulse Generator (IPG) PCBA transport fixture and the implementation of an additional visual inspection step of the microcontroller unit (MCU) prior to final device assembly
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Anesthesiology
- Decision date
- Oct 13, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P130008/S146
- Regulatory pathway
- PMA supplement
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- Decision code
- OK30
- Decision date
- Oct 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.
FDA decision timeline
P130008 · Original PMA
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S146 received
Application receipt date recorded by FDA.
P130008/S146 · FDA decision
30-Day Notice
P130008/S147 · Related supplement
Model 3150 IPG
P130008/S144 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S148 · Related supplement
Model 4063 Dedicated Tray Sealer
Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Inspire Medical Systems | PMA approval | Apr 30, 2014 | FDA | |
Model 3150 IPGP130008/S147 | Inspire Medical Systems | PMA supplement | Oct 22, 2026 | FDA |
INSPIRE II UPPER AIRWAY STIMULATORP130008/S144 | Inspire Medical Systems | PMA supplement | Oct 26, 2026 | FDA |
Model 4063 Dedicated Tray SealerP130008/S148 | Inspire Medical Systems | PMA supplement | Nov 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Inspire Medical Systems
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369
Sources and methodology
- Original FDA record: P130008/S146
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


